Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - NATIONAL HEALTHCARE CORP | ex_225383.htm |
| EX-32 - EXHIBIT 32 - NATIONAL HEALTHCARE CORP | ex_225373.htm |
| EX-31.2 - EXHIBIT 31.2 - NATIONAL HEALTHCARE CORP | ex_225372.htm |
| EX-31.1 - EXHIBIT 31.1 - NATIONAL HEALTHCARE CORP | ex_225371.htm |
| EX-21 - EXHIBIT 21 - NATIONAL HEALTHCARE CORP | ex_225370.htm |
| EX-10.20 - EXHIBIT 10.20 - NATIONAL HEALTHCARE CORP | ex_225369.htm |
| 10-K - FORM 10-K - NATIONAL HEALTHCARE CORP | nhc20201231_10k.htm |
Exhibit 23
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Forms S-8 No. 333-129462, No. 333-167685, No. 333-216085 and 333-238900) pertaining to National HealthCare Corporation’s 2005 Stock Option, Employee Stock Purchase, Physician Stock Purchase & Stock Appreciation Rights Plan and 2004 Non-Qualified Stock Option Plan, 2010 Omnibus Equity Incentive Plan and 2020 Omnibus Equity Incentive Plan of our reports dated February 19, 2021, with respect to the consolidated financial statements and schedule of National HealthCare Corporation, and the effectiveness of internal control over financial reporting of National HealthCare Corporation, included in this Annual Report (Form 10-K) for the year ended December 31, 2020.
/s/ Ernst & Young, LLP
Nashville, Tennessee
February 19, 2021